MC1919A1 - Derives de l'imidazole - Google Patents

Derives de l'imidazole

Info

Publication number
MC1919A1
MC1919A1 MC881959A MC1959A MC1919A1 MC 1919 A1 MC1919 A1 MC 1919A1 MC 881959 A MC881959 A MC 881959A MC 1959 A MC1959 A MC 1959A MC 1919 A1 MC1919 A1 MC 1919A1
Authority
MC
Monaco
Prior art keywords
formula
compound
tert
hydroxy
mixture
Prior art date
Application number
MC881959A
Other languages
English (en)
French (fr)
Inventor
Klotzer Wilhelm
Montavon Marc
Mussner Renate
Singewald Nicolas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1919A1 publication Critical patent/MC1919A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MC881959A 1987-03-20 1988-03-17 Derives de l'imidazole MC1919A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH107387 1987-03-20

Publications (1)

Publication Number Publication Date
MC1919A1 true MC1919A1 (fr) 1989-04-06

Family

ID=4201822

Family Applications (1)

Application Number Title Priority Date Filing Date
MC881959A MC1919A1 (fr) 1987-03-20 1988-03-17 Derives de l'imidazole

Country Status (23)

Country Link
US (1) US4908363A (2)
EP (1) EP0283857B1 (2)
JP (1) JPS63253070A (2)
KR (1) KR880011117A (2)
CN (1) CN1016169B (2)
AT (1) ATE73777T1 (2)
AU (1) AU613349B2 (2)
CS (1) CS276093B6 (2)
DE (1) DE3869163D1 (2)
DK (1) DK59888A (2)
ES (1) ES2032482T3 (2)
FI (1) FI880813A7 (2)
GR (1) GR3004729T3 (2)
HU (1) HU201312B (2)
IL (1) IL85725A (2)
MC (1) MC1919A1 (2)
MX (1) MX10721A (2)
NO (1) NO170215C (2)
NZ (1) NZ223862A (2)
PT (1) PT87025B (2)
SU (1) SU1657057A3 (2)
YU (1) YU46444B (2)
ZA (1) ZA881810B (2)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
US5612360A (en) * 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US5574057A (en) * 1993-02-03 1996-11-12 University Of Utah Research Foundation Naamidine A extracted from sea sponges and methods for its use as an anti-tumor agent
US5523310A (en) * 1994-12-05 1996-06-04 Hoffmann-La Roche Inc. 1,2,3-triazole derivatives
WO2000031052A1 (en) 1998-11-23 2000-06-02 F. Hoffmann-La Roche Ag Synthesis of anti-inflammatory [1,2,3]triazoles
DE10132896A1 (de) * 2001-07-06 2003-01-16 Bayer Cropscience Ag Heterocyclische Amidderivate
WO2003010143A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
JP2004196795A (ja) * 2002-12-16 2004-07-15 Wyeth 外部寄生虫駆除剤としてのｎ−フェニル−３−シクロプロピルピラゾール−４−カルボニトリル
EP1431292A1 (en) * 2002-12-16 2004-06-23 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651844A5 (de) * 1980-07-31 1985-10-15 Alexandr V Ivaschenko 2,2'-azoimidazolderivate, verfahren fuer ihre herstellung, fluessigkristallines material und eine elektrooptische vorrichtung.
DE3674054D1 (de) * 1985-04-26 1990-10-18 Hoffmann La Roche 1,3-disubstituierte imidazoliumsalze.
ZW6687A1 (en) * 1986-05-13 1987-12-02 Hoffmann La Roche 1,3-disubstituted imidazolium salts
MW7087A1 (en) * 1986-10-03 1988-05-11 Hoffmann La Roche 1,3-disubstituted imidazolium salts
JPH02502721A (ja) * 1987-03-20 1990-08-30 イー・アイ・デユポン・デ・ニモアス・アンド・カンパニー 殺菌・殺カビ性アミノトリアゾール及びアミノイミダゾール

Also Published As

Publication number Publication date
AU613349B2 (en) 1991-08-01
DK59888D0 (da) 1988-02-05
ATE73777T1 (de) 1992-04-15
DK59888A (da) 1988-09-21
IL85725A0 (en) 1988-08-31
PT87025A (pt) 1988-04-01
ES2032482T3 (es) 1993-02-16
MX10721A (es) 1993-09-01
CS276093B6 (en) 1992-04-15
EP0283857A1 (de) 1988-09-28
NO881199D0 (no) 1988-03-18
ZA881810B (en) 1988-09-20
JPS63253070A (ja) 1988-10-20
NO170215C (no) 1992-09-23
NO170215B (no) 1992-06-15
YU46444B (sh) 1993-10-20
KR880011117A (ko) 1988-10-26
DE3869163D1 (de) 1992-04-23
IL85725A (en) 1991-12-12
CN88101452A (zh) 1988-10-05
FI880813A0 (fi) 1988-02-22
EP0283857B1 (de) 1992-03-18
PT87025B (pt) 1992-06-30
US4908363A (en) 1990-03-13
HUT49581A (en) 1989-10-30
HU201312B (en) 1990-10-28
FI880813A7 (fi) 1988-09-21
GR3004729T3 (2) 1993-04-28
SU1657057A3 (ru) 1991-06-15
YU40388A (en) 1990-02-28
NZ223862A (en) 1990-08-28
AU1353288A (en) 1988-09-22
NO881199L (no) 1988-09-21
CN1016169B (zh) 1992-04-08
CS8800891A2 (en) 1990-09-12

Similar Documents

Publication Publication Date Title
EP0706512B1 (fr) Derives d'acetamide et leur utilisation comme modificateurs du comportement de prise alimentaire
EP0501892B1 (fr) Dérivés hétérocycliques diazotés N-substitués par un groupement biphénylméthyle, leur préparation, les compositions pharmaceutiques en contenant
BE851310A (fr) Nouveaux derives de la tetrahydro-equinocandine b
FR2530625A1 (fr) Derives d'indole, procedes pour leur preparation et compositions pharmaceutiques les contenant
LU87414A1 (fr) Derives de l'adenosine
CA2180379A1 (fr) Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
CA2152184A1 (fr) Derives de thiazolidine, leur preparation et les medicaments les contenant
FR2667864A2 (fr) Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant.
MC1919A1 (fr) Derives de l'imidazole
MC1696A1 (fr) Derives d'ethylenediaminemonoamide
EP0341231B1 (fr) 1-(1H-imidazol-4-yl)alkyl-benzamides substitués
EP0001193B1 (fr) Amino-acides cycliques, leurs procédés d'obtention et compositions pharmaceutiques les contenant
CA1265804A (fr) Derives de la 1-benzene sulfonyl 2-oxo 5-alcoxy pyrrolidine, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
MC1317A1 (fr) Derives de l'uree
WO2021254453A1 (zh) 氨基吡啶类化合物
CA2074365A1 (fr) Derives de l'uree, leur preparation et les medicaments les contenant
CA1034576A (en) Processes for the preparation of new piperazine derivatives
CA1082716A (fr) Procede de preparation de nouveaux derives de 5- thiazole methane amine
CH630909A5 (en) New 3,5-disubstituted-1H-1,2,4-triazoles
FR2653767A1 (fr) Derives de 1-(aminophenyl)-2-piperidinopropanone, procede et utilisation en therapeutique.
MC1287A1 (fr) Derives de cyclohexadiene
CA1098524A (fr) Procede de preparation de nouveaux derives de l'acide piperazinecarbodithioique
CA1200554A (fr) Procede de preparation de nouveaux derives de l'aminomethyl 14-indole-4-methanol et de leurs sels
MC1568A1 (fr) Derives de benzamide
FR2458552A1 (fr) Nouveaux alcaloides peptidiques de l'ergot de seigle, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
YP Annual fee paid